Clinical Vignettes™: Addressing Challenging Clinical Scenarios in Lung Cancer

Clinical Vignettes™: Addressing Challenging Clinical Scenarios in Lung Cancer is organized by Physicians' Education Resource, LLC (PER).

Release Date: December 24, 2019
Expiration Date: December 24, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
Clinical decision-making for management of patients with lung cancer has changed dramatically over the past few years, with guideline updates every few months and new therapies rapidly transforming treatment paradigms. With recent approvals of targeted and immunotherapeutic strategies, community oncologists face compounding complexity in the decision-making process each time they consider treatment options - and their associated adverse event profiles-for their patients with lung cancer.

This online Clinical Vignette Series educational activity consists of clinical cases and video clips featuring short, expert interviews with oncologists providing evidence-based guidance and perspectives on lung cancer management. This activity will discuss therapeutic decision-making for patients with unresectable stage III NSCLC, metastatic NSCLC with or without actionable mutations, and extensive-stage small-cell lung cancer. The overarching goal of this program is to offer you expert opinions on typical patients with lung cancer that you can integrate immediately into your practice.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Apply key data sets that require consideration in the management of real-world clinical scenarios encountered in the management of lung cancers
• Detail methods to identify, manage, and proactively mitigate the impact of treatment-related toxicities on outcomes in the management of lung cancer cases
• List key planned/ongoing clinical trials in the field investigating emerging strategies for the care of patients with lung cancers

Benefits of Participating:
• How experts approach treatment decisions for a wide range of lung cancer cases
• How to apply new clinical trial data to guide treatment decisions
• How to proactively identify and mitigate toxicities related to systemic lung cancer therapies
• How to optimize outcomes for your patients with lung cancer through informed treatment planning